Terniflorin and bismahanine as potential Bcl-xL inhibitors identified through integrated computational analysis
Breast cancer remains a leading cause of cancer-related mortality worldwide, with dysregulation of apoptosis contributing to tumour progression and therapeutic resistance. The anti-apoptotic protein Bcl-xL is a key regulator of apoptotic evasion and an attractive therapeutic target; however, currently available Bcl-x...